Vascular Surgery Clinical Trial
Official title:
A Phase 3b, Open-Label, Single-Group Immunogenicity and Safety Study of Topical Recombinant Thrombin (rThrombin) in Surgical Hemostasis
The purpose of this study is to evaluate the safety and immune system response to recombinant thrombin when used to control bleeding in spinal and vascular surgery.
This is a Phase 3b, open-label, single-group, multisite safety and immunogenicity study of recombinant thrombin (rThrombin) in participants who are at least 18 years of age and undergoing spinal or vascular surgery. Eligible participants will receive topical rThrombin during surgery and complete a 1-month follow-up visit. ;
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03681834 -
Multi-center Register for the Use of the Cor-Knot® Automated Knotting System in Heart Valve Surgery
|
||
Active, not recruiting |
NCT01558596 -
Remote Ischemic Preconditioning Prior to Vascular Surgery
|
Phase 1/Phase 2 | |
Recruiting |
NCT05968456 -
Complexity and Frailty in Cardiothoracic and Vascular Anesthesia (CAfCA). Prospective Multicentric Observational Study
|
||
Completed |
NCT04137991 -
Nol-Index Guided Remifentanil Analgesia Versus Standard Analgesia During Moderate-to-High Risk Cardiovascular Surgery
|
N/A | |
Terminated |
NCT00244504 -
Moxonidine in Patients Undergoing Vascular Surgery
|
Phase 3 | |
Terminated |
NCT02254642 -
Effects of Ischemic Preconditioning After Aortic Clamping
|
N/A | |
Recruiting |
NCT06248775 -
Nursing Prehabilitation Intervention Supported With Technology for Vascular Surgery in People With Type 2 Diabetes
|
N/A | |
Completed |
NCT04169217 -
POWER: PrehabilitatiOn Workshop and Mentored Exercise Programme in Patients Having Elective Aortic Aneurysm Repair
|
N/A | |
Terminated |
NCT01897519 -
A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery
|
Phase 2 | |
Recruiting |
NCT02863250 -
Australian and New Zealand Massive Transfusion Registry
|
||
Completed |
NCT00873704 -
Supplemental Oxygen in Vascular Surgery
|
N/A | |
Not yet recruiting |
NCT06222866 -
Anticoagulation and Inflammation Monitoring in Patients After Heart and Vascular Interventions
|
||
Completed |
NCT03215446 -
Evaluate the Muscle Protection Effect of Sevoflurane Sedation in Vascular Surgery
|
Phase 4 | |
Completed |
NCT00610545 -
Atorvastatin in Perioperative Vascular Surgery - Pilot Study
|
Phase 4 | |
Completed |
NCT00712023 -
Effect of Forced-air Warming and Circulating-water Mattress in Preventing Heat Loss During Vascular Surgery
|
Phase 2 | |
Recruiting |
NCT05614869 -
Continuous Treatment With PREVENA Therapy for 14 Days
|
N/A | |
Recruiting |
NCT06159517 -
Heart Lung Machine Registry
|
||
Recruiting |
NCT03926104 -
BNP and Vascular Surgery
|
||
Not yet recruiting |
NCT04053894 -
Association of PeriOPerative Aspirin-ResisTance and CardioVascular Outcome
|
||
Recruiting |
NCT03883763 -
Hyperbaric Novabupi® in Spinal Anesthesia in Lower Limbs Vascular Surgery
|
Phase 3 |